DIAGNOSTIC CONCORDANCE BETWEEN NEXT-GENERATION AND HIGH SENSITIVE TROPONIN-I IN ANGINA PECTORIS PATIENTS

Anticardiolipin and Antiphospholipid Antibodies in Iraqi Patients with Angina Pectoris

Comparison between Revascularization and Optimal Medical Therapy in Patients with Stable Angina Pectoris

Background and Purpose: Regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging. The aim of this 12-month follow-up study was to compare the survival benefit associated with revascularization versus optimal medical therapy on the patients with stable angina pectoris. Materials and Methods: A prospective clinical s...

High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris.

BACKGROUND We determined whether high-sensitivity cardiac troponin I can improve the estimation of the pretest probability for obstructive coronary artery disease (CAD) in patients with suspected stable angina. METHODS AND RESULTS In a prespecified substudy of the SCOT-HEART trial (Scottish Computed Tomography of the Heart), plasma cardiac troponin was measured using a high-sensitivity single...

[Troponin release following exercise test in patients with stable angina pectoris - risk factors and prognostic significance].

BACKGROUND Increase of troponin (cTn) is a marker of myocardial injury caused by different mechanisms. Exercise testing (ExT) is a useful clinical tool in predicting the risk of myocardial ischemia, especially in patients with multivessel coronary artery disease (CAD), who are more often endangered by medical complications. The test is however limited by its low sensitivity and specificity. A...

Nonconventional therapeutic modalities in refractory angina pectoris

    Abstract   Despite sophisticated conventional medical treatment and the continued development   and improvement of coronary revascularization modalities in recent years, a significant   number of patients still suffer from refractory angina pectoris and cannot be successfully   managed. Advances in therapeutic options have led to an increase in the average of life   expectancy even in such ...